Sanofi India Limited (SIL) recently obtained approval from its board of directors for an exclusive distribution and promotion agreement with Emcure Pharmaceuticals Limited (Emcure).
The UK Medicines and Healthcare Products Regulatory Agency (MHRA) has granted marketing authorization to Daiichi Sankyo UK Ltd.
NephroPlus, a multinational leader in dialysis care and Asia's largest dialysis network announces the recent acquisition of Renal Therapy Solutions Inc. (RTSI), a well-known dialysis network with six clinics in the Philippines.
Pfizer Inc. recently announced positive results from a phase 3 clinical study of the antibody-drug conjugate Adcetris (brentuximab vedotin), used in combination with lenalidomide and rituximab for treating patients
Recently, an impactful one-day seminar on a capacity-building program for pharmacovigilance was held in Nashik, India.
The Department of Pharmaceuticals (DoP) recently issued a Uniform Code for Pharmaceutical Marketing Practices (UCPMP) to regulate unethical practices in the pharma industry.
Medical Fair India 2024 is set to return to Mumbai, providing a premier platform for the exhibition and conference of cutting-edge healthcare technologies and equipment.
Kerala state is currently grappling with an outbreak of mumps, with 190 cases being reported in a single day on March 10.
Involution Healthcare is pleased to announce the virtual inauguration of its state-of-the-art Stent Manufacturing Facility in Jaipur.
Esteemed business executives, government regulators, and technology innovators recently convened at the Future-Ready Supply Chain Summit to collectively envision a transformative path for pharmaceutical supply chains of the future.